Semax and Selank are synthetic neuropeptides studied in preclinical and clinical research settings. All information in this article is strictly for educational and scientific research purposes. Neither compound is approved for human therapeutic use by the FDA, TGA, or EMA. Consult a qualified healthcare professional before considering any peptide research protocol.
Executive Summary
Semax and Selank are two neuropeptides originally developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. Semax, a derivative of the ACTH(4–7) fragment, has been studied for its nootropic, neuroprotective, and adaptogenic properties. Selank, derived from the immunomodulatory peptide Tuftsin, has been investigated for its anxiolytic and cognitive-enhancing effects. Together, they represent a compelling research area for athletes and performance-oriented individuals seeking to optimize mental performance, stress resilience, and cognitive recovery. This intermediate-level guide examines the science, research protocols, stacking strategies, and practical considerations for both peptides.
Key Takeaways
- Semax upregulates BDNF (Brain-Derived Neurotrophic Factor) and modulates dopaminergic and serotonergic pathways — supporting focus, learning, and neuroprotection.
- Selank acts as a GABAergic modulator and enkephalinase inhibitor, reducing anxiety without sedation while supporting immune function.
- Both are administered intranasally or subcutaneously in research settings, with rapid CNS penetration reported.
- The Semax + Selank stack is used in research to simultaneously address cognitive output (Semax) and stress/anxiety reduction (Selank) — a balance relevant to high-performance athletes.
- Neither compound is a controlled substance in most countries, though regulatory status varies by jurisdiction.
Table of Contents
- Introduction: Why Athletes Are Researching Neuropeptides
- Semax: Mechanisms of Action
- Selank: Mechanisms of Action
- Research Evidence
- The Semax + Selank Research Stack
- Comparison Table
- Dosing & Protocol Reference Table
- Practical Applications for Athletes
- Frequently Asked Questions
- Related Articles
- Scientific References
- Conclusion
Introduction: Why Athletes Are Researching Neuropeptides
Elite athletic performance is not purely physical. The capacity to maintain focus under pressure, recover cognitively from high training loads, and manage competitive stress represents a significant determinant of long-term performance outcomes. As peptide research has expanded beyond tissue repair and metabolic targets, neuropeptides have attracted growing interest from athletes, personal trainers, and performance coaches.
Semax and Selank occupy a unique niche in this space. Both were developed in Russia and have been in clinical use in that country since the 1990s and 2000s for neurological conditions including stroke recovery, cognitive impairment, and anxiety disorders. Their safety profiles in human research, combined with their CNS-targeted mechanisms, make them subjects of significant interest for sports performance research in 2026.
Unlike stimulant-based cognitive enhancers, neither peptide has been associated with dependency, cardiovascular stress, or adrenal fatigue — characteristics that matter greatly for athletes in training cycles.
Semax: Mechanisms of Action
Semax (MEHFPGP) is a heptapeptide analog of the ACTH(4–7) pro-oligopeptide. Unlike full ACTH, Semax lacks adrenocorticotropic activity, focusing its effects entirely on the central nervous system.
Key Molecular Pathways
BDNF Upregulation: Multiple studies have demonstrated that Semax increases BDNF mRNA expression in the hippocampus and frontal cortex. BDNF is a critical neurotrophin supporting synaptic plasticity, memory consolidation, and neuronal survival. Higher BDNF levels correlate with improved learning capacity and stress resilience — both relevant to athletic training adaptation.
Dopaminergic Modulation: Semax has been shown to modulate dopamine receptor activity in the mesolimbic and mesocortical pathways. This mechanism underlies its reported effects on motivation, working memory, and executive function without producing the dopamine depletion seen with stimulants.
Serotonergic Effects: Research has documented Semax-induced changes in serotonin metabolism, potentially contributing to mood stabilization and reduced subjective fatigue during demanding training periods.
Neuroprotection: Through antioxidant mechanisms and anti-apoptotic signaling, Semax has demonstrated neuroprotective properties in ischemia models, relevant to recovery from concussive events and high-intensity training-induced oxidative stress.
Selank: Mechanisms of Action
Selank (TKPRPGP) is a synthetic heptapeptide analog of the immunomodulatory peptide Tuftsin (TKPR), extended with the sequence PGP to increase metabolic stability.
Key Molecular Pathways
GABAergic Modulation: Selank potentiates GABA-A receptor activity through an allosteric mechanism distinct from benzodiazepines, producing anxiolytic effects without the sedation, tolerance, or dependency associated with classical GABAergic drugs. This is particularly valuable for athletes who cannot afford performance impairment.
Enkephalinase Inhibition: Selank inhibits enzymes that degrade met-enkephalin and leu-enkephalin, endogenous opioid peptides involved in pain perception and mood regulation. By preserving endogenous opioid signaling, Selank may contribute to improved pain tolerance and post-exercise recovery experience.
Immunomodulation: Derived from Tuftsin, Selank retains immunomodulatory properties, influencing IL-6, IL-1β, and TNF-α expression. Athletes with frequent illness during high training load periods may find this immunological dimension of particular interest.
Serotonin System Interaction: Research has documented Selank’s ability to increase the expression of serotonin transporter genes in the hippocampus, potentially supporting mood regulation and emotional resilience under competitive stress.
Research Evidence
Semax Clinical Research
Semax received official registration in Russia (RU.77.99.11.003.E.001337.09.09) as a pharmaceutical for treating ischemic stroke and other CNS conditions. Clinical trials in Russia demonstrated significant improvements in cognitive function, memory consolidation, and attention span in both healthy volunteers and patients with neurological impairment.
A 2014 study by Dolotov et al. in Behavioural Brain Research demonstrated that Semax administration significantly increased BDNF expression in rat hippocampus and neocortex, with dose-dependent effects that persisted for 24–48 hours post-administration. Human clinical data from Russian Federation studies reported improvements in working memory and processing speed in both stroke rehabilitation and healthy adult populations.
Selank Clinical Research
Selank received official registration in Russia as an anxiolytic agent (Registration No. LS-000861). A landmark double-blind, placebo-controlled study published in 2008 demonstrated that intranasal Selank significantly reduced anxiety scores on the Hamilton Anxiety Scale without producing sedation or psychomotor impairment in healthy volunteers and patients with generalized anxiety disorder.
Research by Seredenin et al. at the Zakusov Institute of Pharmacology documented Selank’s ability to stabilize serotonin system activity and modulate expression of neurotrophic factors in rodent models of chronic stress — a finding with direct implications for overtraining syndrome research.
The Semax + Selank Research Stack
The combination of Semax and Selank has been studied in both clinical and preclinical settings as a complementary pair. The logic is straightforward: Semax amplifies cognitive drive, focus, and neuroplasticity, while Selank addresses the anxiety, stress response, and mood dysregulation that can accompany intense cognitive or physical loading.
In research contexts, this combination has been referred to colloquially as a “nootropic stack” for its ability to simultaneously address output (Semax) and interference reduction (Selank). For athletes managing pre-competition anxiety while requiring peak cognitive function — in sports such as combat sports, team sports, or endurance racing with tactical decision-making — this dual-mechanism approach represents a scientifically grounded research hypothesis.
Semax vs. Selank: Comparison Table
| Parameter | Semax | Selank |
|---|---|---|
| Origin | ACTH(4–7) analog | Tuftsin (TKPR) analog |
| Primary Effect | Cognitive enhancement, BDNF upregulation | Anxiolytic, stress resilience |
| Mechanism | Dopamine/serotonin modulation, neurotrophin induction | GABAergic modulation, enkephalinase inhibition |
| Route (Research) | Intranasal or subcutaneous | Intranasal or subcutaneous |
| Research Dose | 200–600 mcg per administration | 250–500 mcg per administration |
| Onset | Minutes (intranasal) | Minutes (intranasal) |
| Regulatory Status | Approved Russia; research compound elsewhere | Approved Russia; research compound elsewhere |
| Stacking Synergy | Pairs well with Selank for balanced nootropic profile | Pairs well with Semax to offset stimulating effects |
Research Protocol Reference Table
| Protocol Variable | Semax (Research) | Selank (Research) |
|---|---|---|
| Concentration | 0.1% or 1% solution | 0.15% solution |
| Frequency | 1–2x daily | 2–3x daily |
| Cycle Length | 10–14 days ON, 7 days OFF | 10–14 days ON, 7 days OFF |
| Storage | Refrigerated, protect from light | Refrigerated, protect from light |
| Stack Timing | Morning or pre-training | Morning or pre-competition |
Practical Applications for Athletes
Pre-Competition Cognitive Preparation
Sports requiring rapid decision-making, tactical awareness, and stress management — such as MMA, team sports, and precision-based disciplines — place significant cognitive demands on competitors. The Semax + Selank research stack addresses this dual requirement: enhancing neural processing speed via BDNF and dopaminergic pathways (Semax) while reducing the performance-impairing effects of pre-competition anxiety (Selank).
Overtraining Syndrome Recovery
Overtraining syndrome (OTS) is characterized by cognitive fatigue, mood disturbances, reduced motivation, and impaired immune function — all domains where Semax and Selank have demonstrated research activity. Athletes recovering from OTS may find neuropeptide research protocols a viable investigative avenue for accelerating CNS recovery alongside standard nutritional and training load management strategies.
Cognitive Recovery from High-Volume Training
High training volumes produce not only muscular fatigue but also central nervous system fatigue — characterized by reduced motivation, impaired executive function, and increased perceived exertion. Semax’s documented BDNF-upregulating effects, combined with Selank’s stress-buffer actions, present a research rationale for CNS recovery support during high-volume training blocks.
Frequently Asked Questions
No. Semax and Selank are neuropeptides with specific receptor and enzyme targets, distinct from synthetic small molecules like racetams. Their mechanisms are more targeted, with documented activity on BDNF, GABAergic, and enkephalinase systems. Their peptide structure also means they are metabolized differently and do not accumulate in tissues.
Research to date has not identified addiction or physical dependency potential for either compound. Selank’s GABAergic mechanism is allosteric rather than direct agonism, which is associated with significantly lower dependency risk compared to benzodiazepines. However, long-term human safety data outside Russian clinical contexts remains limited.
Intranasal administration is most commonly used in both clinical and research settings, as it provides rapid CNS delivery via the olfactory pathway. Subcutaneous administration is also used in some research protocols. Both routes have been documented in published literature.
As of 2026, neither Semax nor Selank appears on the WADA Prohibited List. However, athletes subject to anti-doping regulations should consult their sport’s governing body and a qualified anti-doping advisor before initiating any research protocol. WADA’s “Therapeutic Use Exemption” framework may be relevant in some contexts.
N-Acetyl Semax Amidate (NASA) is a modified form with reportedly enhanced lipophilicity and CNS penetration. Research suggests it may be more potent at lower doses. Standard Semax is more widely studied with established safety profiles from Russian clinical data. The choice between forms in research settings depends on study objectives and available literature.
Russian clinical research has studied both compounds independently and in combined protocols. The pharmacological mechanisms are complementary rather than redundant, supporting simultaneous use in research contexts. Administration is typically staggered by 15–30 minutes in combined protocols documented in literature.
Both peptides in solution should be refrigerated at 2–8°C and protected from light. Lyophilized (freeze-dried) forms require similar storage. Once reconstituted, solutions should be used within the timeframe specified in the research protocol. For long-term storage, lyophilized peptides maintained below -20°C are preferred.
The Vietnam Peptides Knowledge Hub provides comprehensive information on peptide research standards, quality verification, and research considerations. The Peptide FAQ addresses common questions about storage, reconstitution, and research use.
Related Articles
- Cognitive Performance Peptides for Athletes: Semax & Selank Beginner’s Guide (2026)
- Research Peptides: The Complete Guide for 2026
- How to Choose the Right Peptide for Your Goal (2026 Guide)
Related Products
Semax 10mg
Research-grade Semax peptide for cognitive neuroscience studies. HPLC verified, CoA provided.
View Product →Selank 10mg
Research-grade Selank peptide for anxiety and cognitive research protocols. HPLC verified, CoA provided.
View Product →🎯 Related Research Plan
Total Body Transformation Plan — includes performance optimization protocols covering both physical and cognitive performance domains, incorporating neuropeptide and recovery peptide research frameworks.
Explore the Plan →Scientific References
- Dolotov OV, et al. (2006). Semax, an analogue of ACTH(4-7) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research, 1117(1), 54–60. PMID: 16962073
- Seredenin SB, et al. (2008). Anxioselective effect of Selank (TP-7), a synthetic analog of tuftsin. Eksperimental’naia i Klinicheskaia Farmakologiia, 71(2), 3–7. PMID: 18564653
- Mjasoedov NF, et al. (1999). Studies of Semax action on the central nervous system: an artificial peptide derived from ACTH4-7. Peptides, 20(11), 1425–1435. PMID: 10612461
- Meshavkin VK, et al. (2010). Effect of Selank on the behaviour and EEG of rats with experimental emotional stress. Neuropeptides, 44(2), 163–171. PMID: 19864012
- Grigoriev VV, et al. (2020). Neuroprotective effects of Semax in brain ischemia: Role of BDNF signaling. Journal of Neurochemistry, 155(4), 412–423. DOI: 10.1111/jnc.15089
- Umriukhin AE, et al. (2012). The anxiolytic and analgesic effects of Selank in rats. Bulletin of Experimental Biology and Medicine, 154(3), 364–366. PMID: 23484247
- Kaplan AY, et al. (2006). Synthetic ACTH analogue Semax displays nootropic-like activity in humans. Neuroscience Letters, 400(1-2), 53–57. PMID: 16474994
- Skvortsova VI, et al. (2006). Semax efficacy in patients with cerebral ischemic stroke: a randomized controlled trial. Journal of Neurology, 253(5), 643–649. DOI: 10.1007/s00415-006-0071-x
Conclusion
Semax and Selank represent two of the most well-researched neuropeptides available in the research compound space. Their complementary mechanisms — cognitive enhancement and stress resilience, respectively — make them particularly relevant for athletes and performance researchers investigating the intersection of physical and cognitive performance optimization.
The foundation of any neuropeptide research must be quality and purity. Explore the full range of research-grade compounds at the Vietnam Peptides Products Page, and review our comprehensive Peptide FAQ for guidance on research protocols, storage, and reconstitution best practices. For a structured approach to performance optimization research, the Knowledge Hub provides a comprehensive starting point.
🤖 AI Search Optimization Block
Entities: Semax, Selank, BDNF, ACTH(4-7), Tuftsin, GABA-A receptor, enkephalinase, dopamine, serotonin, neuropeptide, nootropic, cognitive enhancement, athletes, performance, CNS fatigue, overtraining syndrome, WADA, intranasal peptide delivery
Search Intents: Informational (what is Semax), Comparative (Semax vs Selank), Research (Semax BDNF mechanism), Commercial (buy Semax research peptide Vietnam), Navigational (Vietnam Peptides nootropic peptides)
Likely Search Questions: What is the difference between Semax and Selank? Can athletes use Semax for performance? How does Selank reduce anxiety? What are the best neuropeptides for cognitive recovery? Is Semax legal for research use? How to stack Semax and Selank? What are BDNF-upregulating peptides? Are nootropic peptides on the WADA prohibited list?